Supporting Women With Breast Cancer to Practice DIBH at Home Before Radiation Therapy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorJonkoping University

About this trial

To examine the effect of a preparatory digital tool including a new instruction for deep inspiration breath hold (DIBH), before start of radiation therapy in women diagnosed with left sided breast cancer, compared with usual care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients > 18 years of age

with a left-sided breast cancer diagnosis or DCIS

who are to receive RT with DIBH technology

with curative intention

Disqualifiers

patients receiving palliative RT or neoadjuvant chemotherap

Planning CT starting < 7 days

people with some form of orthopedic, rheumatological or neurological injury or disease that limits the possibility of carrying out the intervention.

Trial design

Design model

Parallel

Treatments tested in this trial

  • mobile application with breathing instructions and a sensor to attach around the chest. To be able to train at home before radiotherapy with DIBH starts.

    Other intervention

    The DIBH-App consists of 1) a mobile application that patients download to their own smart mobile phone, and 2) associated stretch-sensors that are attached around the chest and connected to the mobile phone via Bluetooth. Visually, the graphics is similar to the software used for DIBH in the RT department. Coaching takes place through instructional videos, text, and audio recordings (Image 2). The following information will be recorded and stored: date and time of practice, outcome of each session (including sensor data and calibration parameters), and user behavior within the application (such as screen visits, FAQ sections viewed, and key button presses).

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: A=Control group who receives customary information prior to RT with DIBH.No intervention 0 interventions
Group B: B=Intervention group usual care and the DIBH-App to practice at-home before RT with DIBH.Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Distress (DIS-A)

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Time frame
Time 1, baseline at randomisation/inclusion
2

Distress (DIS-A)

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Time frame
time 2, at CT-planning visit one week
3

Distress (DIS-A)

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Time frame
time 3, 3 weeks post RT
4

Distress (DIS-A)

The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale, where 0 is no distress and 10 the worst distress.

Time frame
time 4, 6 month post RT

Secondary outcomes

1

HRQoL and Health economic (EQ-5D-5L)

Health economic measured with EQ-5D-5L a health-related quality of life instrument used to calculate quality-adjusted life years (QALY) . Its design accounts for the need for a direct link between the measurement and valuation of health, whereby every health state that patients might report on the EQ-5D-5L instrument can be summarised by a single value. In order to be used in the calculation of quality-adjusted life years (QALYs; a metric used in cost-utility anal-ysis that combines survival and HRQL), these values need to summarise how good or bad each health state is on a scale anchored at 1 (full health) and 0 (a state equivalent to dead). Values less than 0 represent health states considered to be or modelled as worse than dead.

Time frame
at baseline when inclusion/randomisation
2

HRQoL and Health economic (EQ-5D-5L)

Health economic measured with EQ-5D-5L a health-related quality of life instrument used to calculate quality-adjusted life years (QALY) . Its design accounts for the need for a direct link between the measurement and valuation of health, whereby every health state that patients might report on the EQ-5D-5L instrument can be summarised by a single value. In order to be used in the calculation of quality-adjusted life years (QALYs; a metric used in cost-utility anal-ysis that combines survival and HRQL), these values need to summarise how good or bad each health state is on a scale anchored at 1 (full health) and 0 (a state equivalent to dead). Values less than 0 represent health states considered to be or modelled as worse than dead.

Time frame
5 years post RT
3

e-HL (eHLQ)

eHealth Literacy Questionnaire-Swedish version, aims to measure a broad range of literacy skills, which could make it useful in assessing the effects of strategies for delivering online information and applications. eHEALS is an 8-item instrument with each item scored on a 5-point Likert scale.Each item is rated on a 5-point. Likert scale, ranging from 1 = strongly disagree to 5 = strongly agree.

Time frame
at baseline when inclusion/randomisation
4

Communicative, critical and functional HL

consists of 14 statements with 4 points Likert scales (1-4). The statements ask how often (never to often) patients have trouble with reading or understanding leaflets from healthcare providers/hospital or pharmacy (functional health literacy; 5 items), have difficulty (easy to rather difficult) performing certain actions in relation to health information (communicative (5 items) and critical (4 items) health literacy).

Time frame
at baseline when inclusion/randomisation

Other outcomes

1

Logged data from the CT machine

will be collected at all treatment occasions on all included patients. Estimation of time for planning CT (min)

Time frame
at Ct planning visit, one week
2

Logged data from the CT machine

number of correct and failed breathing attempts that the patient needs for approved CT. (nr of CT)

Time frame
at Ct planning visit, one week
3

Data from the journal

Data from the journal on all included patients, looking at extra visits for making planning CT.

Time frame
at Ct planning visit, one week
4

Logged data from the RT machine

Logged data from radiation treatment devices (linear accelerators) will be collected at all treatment occasions on all included patients. Estimation of time on RT

Time frame
at Ct planning visit, one week

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: